Login to Your Account

Financings Roundup

Tissue Regenix Brings in $39M To Advance dCell Technology

By Nuala Moran
BioWorld Today Correspondent

Tuesday, December 13, 2011
LONDON – Closing the year with some cheer for the sector, Tissue Regenix Group plc has raised £25 million (US$39 million) in a placing, enabling the regenerative medicine specialist to begin to advance several programs in parallel.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription